SCRA Member Companies receive mentoring support and are eligible to apply for grant funding and an investment from SC Launch, Inc. Graduate companies have successfully launched out of the program. Companies are aligned with Information Technology, Life Sciences or Advanced Manufacturing and Materials sectors.

167 Result(s)
  • Date (Newest first)
  • Date (Oldest first)
  • Title A to Z
Refine Search

Grant Funding | Life Sciences MIPY has developed, designed and patented a simpler solution for epinephrine delivery, which is typically used to combat severe allergic reactions. The company’s solution is much smaller, uses less parts, requires less force to activate and promises to be a less expensive alternative to current epinephrine auto-injectors. Additionally, other medications can be loaded into the MIPY device to help reduce cost of auto-injector medications. Through strategic partnerships with organizations such as …

Grant Funding | Advanced Material and Manufacturing 
Miravan is the company formed to bring Moozi to market. Moozi is the patented solution for preparing perfect temperature formula bottles in under a minute. Moozi leverages the coffee pod revolution with a feeding solution technology that provides an easy and safe method for formula bottle preparation.
Visit Company Website 

Life Sciences 
Mitochem Therapeutics has developed a class of small molecules, mitoalexins, that protect mitochondria in tissues from the metabolic stress that causes many degenerative diseases. The primary indications are retinal degenerative diseases and Mitochem is in INDenabling studies of a lead molecules for treatment of retinitis pigmentosa, a rare disease with an etiology similar to age related macular degeneration. Other indications include glaucoma and neurodegenerative diseases.…

Portfolio Company | Information Technology  Modjoul’s description: Our mission is to improve the safety record of every company by providing data and actionable insights to eliminate employee injuries …

Portfolio Company | Information Technology 
MOONDOG Animation Studio is a seasoned squad of adventurers based out of Mount Pleasant, SC in the Charleston, SC area. From here, we’re tackling the major motion animated film market head-on. We create:Full-length animated feature films, Short films, Virtual reality films,Animated architectural visualizations, Commercial and marketing campaigns.  But no matter the subject matter, our mission is always to deliver engaging stories, with compelling characters, rendered with the utmost expertise and quality.
Visit Company Website 

Grant Funding | Life Sciences 
Neuroene Therapeutics is a biotechnology company developing novel therapies for epilepsy. Approximately 1 million people in the U.S. have seizures that are not well controlled by medications currently on the market. The company’s Vitamin K-based therapeutics are nontoxic and target new mechanisms that are different to the currently available drugs.
Visit Company Website 

Portfolio Company · Landing Party | Life Sciences 
Israeli American Biotechnology company, dedicated to early detection of cognitive disorders such as Alzheimer's disease through the discovery of immune markers in patients prior to the onset of symptoms.…

Grant Funding | Advanced Materials and Manufacturing 
Palmetto Propulsion is researching and developing new technologies that will provide more efficient, lower cost, and safer propulsion systems for recreational, commercial and military markets. The new marine propulsion systems are aimed at replacing the bladed propellers that are widely used today.
Visit Company Website 

Portfolio Company · Landing Party | Information Technology 
Digital media technology company with proprietary technologies to dynamically customize video. Their campaign driven SaaS platform for media publishers helps drive real revenue through in-content solutions, keeping consumers engaged by bringing them relevant content.
Visit Company Website 

Portfolio Company · Grant Funding | Information Technology 
PEC360 provides patient engagement technology and services to healthcare systems.
Visit Company Website 

 Grant Funding | Life Sciences  Pensievision, Inc. has developed a 3D medical imaging technology for early-stage detection and analysis of cancers, initially focusing on cervical cancer. The company’s imaging platform provides instant diagnostics, on location, avoiding the need for lab infrastructure, reducing waiting times and reducing additional visits to the clinic. In 2018, the company was awarded a National Science Foundation Small Business Innovation Research grant to further research and development. Pensievision aims to provide more favorable cancer screening methods that are easier to use, more accessible and lower cost.

Portfolio Company | Life Sciences PharmRight is focused on enabling individuals to live independently by providing innovative solutions for home healthcare using telehealth, information and communication technologies. 

Graduate | Portfolio Company | Life Sciences 
Phi Life Sciences is a Molecular Diagnostic and Laboratory Service company that aims to improve the efficiency, delivery, accessibility, and utility of molecular testing results and services. Novel technologies licensed and products developed will empower physicians to deliver precision treatments and diagnoses by incorporating molecular tests that will improve their patients’ health. Visit Company Website 

Client Company | Information Technology 
PowerSport Technologies is a fully customizable software solution that is revolutionizing the powersports industry. Created for powersports dealers by powersports lovers, the company’s solution generates more leads, sales and revenue by integrating with major Dealer Management Systems, superior OEM data, automated data feeds and OEM parts. By pre-loading thousands of parts and accessories to the website, PowerSport Technologies is turning a dealer’s website from an expense to a profit center by offering 24/7 online shopping for customers. Visit Company Website

Grant Funding | Life Sciences
PPI Pharmaceuticals was founded as a spin-off company from the University of South Carolina to develop next generation cancer therapeutics by utilizing novel technology to exploit protein-protein interactions. Theses cancer drugs will be more selective for tumors than traditional cancer agents thereby improving efficacy while decreasing side effects and toxicity.…